Popular Articles

Arena Pharmaceuticals Announces The Presentation Of Lorcaserin Phase 3 BLOOM Data At The American Diabetes Association's 69th Scientific Sessions
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that a late-breaking abstract of its lorcaserin Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association"s 69th Scientific Sessions in New Orleans, Louisiana. The abstract, titled "Lorcaserin Reduces Body Weight in Obese and Overweight Subjects: Behavioral Modification and Lorcaserin for Overweight and Obesity Management, the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. Central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in category 20-B Obesity - Clinical Treatment.
buy viagra
Project To Develop HIV/AIDS Strategy For Libya Led By Liverpool School Of Tropical Medicine
Liverpool School of Tropical Medicine (LSTM) is leading a project to provide technical assistance to the Libyan government to finalise the development of a national HIV strategy and programme of support. The project is supported by a 1 million euro grant from the Delegation of the European Commission to Libya.
News of the day
Policymakers, Experts, Public Agree: Physical Activity Plan Needed
Dozens of the nation"s leading organizations in health care, science, medicine and public health are meeting in Washington, D.C., this week with one goal in mind: to develop a national physical activity plan that will make America healthier. Congressional leaders and members of the public both agree that emphasizing disease prevention measures, such as increasing physical activity, is essential to combating chronic diseases, which account for 70 percent of all deaths in the U.S., according to the Centers for Disease Control and Prevention.
Nutrition

Numbers Of People With MS Higher Than Previously Estimated

New research released by the MS Society has for the first time revealed an accurate estimate of the number of people living with a diagnosis of multiple sclerosis (MS) in the UK. The results show that there is likely to be around 100,000 people with MS in the UK - a 20 per cent increase on previous estimates. The new study of GP records - funded by the MS Society - was carried out by the London School of Hygiene and Tropical Medicine and updates previous estimates of 85,000. The revised figure has major implications for health and social services and the study is a precursor to a pilot MS Register, which will provide much more information on exactly how MS affects individuals. MS Society Chief Executive, Simon Gillespie, said: "For the first time, we have the right information on the numbers of people with MS. Based on this information, we will seek to work with local health and social services across the UK to improve services for people with MS. "This is just the beginning. As part of its leadership of a European initiative, the MS Society will now fund a pilot MS Register, which will provide much more information on how MS affects individuals. "If this pilot proves successful, we hope the governments in all four nations of the UK will support the introduction of a complete register." The study was brought about following work carried out by MS Society members in Hampshire, who found that in their local area, the previous estimated prevelance rate was inaccurate. Knowing how many people have MS is important so that health and social services can provide the right types of care and support. In many areas of the country people do not currently have access to all the nursing care, drugs and treatment regime that they so desperately need. Read the full Strength in Numbers briefing document - MS prevalence study briefing June 2009.pdf (201 kb) Download the Strength in Numbers campaign leaflet - Strength in Numbers.pdf MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):